Have you considered the possibility that your small cap biotech is running predominantly on retail holders, that the institutional funds are not worried about the stock you mention.That it is behaving as you would expect in the absence of big boys predominantly.
Consider that RCE is well and truly in the crosshairs of big pharma and the institutions, that they do not want RCE to run until they have their fill. That they are soaking up the volume of small guys selling in frustration and will continue to do so until satisfied.
Just a few possibilities RED
RCE Price at posting:
$1.18 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)